Synaptotagmin-like Protein 1 is a Potential Diagnostic and Prognostic Biomarker in Endometrial Cancer Based on Bioinformatics and Experiments
Overview
Reproductive Medicine
Authors
Affiliations
Endometrial cancer (EC) is one of the most common gynecologic malignancies. Identification of potential EC biomarkers is essential to improve the prognosis and development of therapies against EC. Synaptotagmin-like protein 1 (SYTL1), as a small GTPase Rab27 effector, mainly plays a role in vesicle trafficking and cytotoxic granule exocytosis in lymphocytes. However the role of SYTL1 in EC remains uncertain. We performed a comprehensive assessment of the relationship between SYTL1 and patient diagnosis and prognosis by analysis of EC patients' data from TCGA. We employed the LinkedOmics and Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database to analyze the biological function of SYTL1 in EC. In addition, the correlation between SYTL1 expression and its DNA methylation was performed by using cBioportal, UALCAN, TCGA Wanderer and MethSurv databases. We further assessed the link between SYTL1 and tumor-infiltrating immune cells by using gene set variation analysis (GSVA).Results We found that SYTL1 was highly expressed in EC patients and cell lines. And increased expression of SYTL1 was associated with age, clinical stage, histological type, histological grade and good overall survival (OS).SYTL1 DNA methylation is negatively associated with SYTL1 expression and UCEC patients' OS. SYTL1 expression is closely correlated with immune infiltration. Furthermore, we carried out in vitro experiments to verify the results of bioinformatic analysis.Conclusion Our results demonstrated that the elevation of SYTL1 expression is associated with good OS and SYTL1 might be a potential diagnostic and prognostic marker in EC.
Unveiling DNA methylation: early diagnosis, risk assessment, and therapy for endometrial cancer.
Li M, Xia Z, Wang R, Xi M, Hou M Front Oncol. 2025; 14:1455255.
PMID: 39902129 PMC: 11788147. DOI: 10.3389/fonc.2024.1455255.
Novel Interacting Partners of MGP-40, a Chitinase-Like Protein in Buffalo Mammary Epithelial Cells.
Vijay Anand J, Jaswal S, Jena M, Kumar S, Kaushik J, Mohanty A Cell Biochem Biophys. 2024; .
PMID: 39579292 DOI: 10.1007/s12013-024-01623-z.
Uomoto M, Ota Y, Suzuki Y, Yumori A, Narimatsu H, Koizume S BMC Cancer. 2024; 24(1):1058.
PMID: 39192208 PMC: 11351603. DOI: 10.1186/s12885-024-12827-0.
The AKT2/SIRT5/TFEB pathway as a potential therapeutic target in non-neovascular AMD.
Ghosh S, Sharma R, Bammidi S, Koontz V, Nemani M, Yazdankhah M Nat Commun. 2024; 15(1):6150.
PMID: 39034314 PMC: 11271488. DOI: 10.1038/s41467-024-50500-z.
Xu S, Xu Y, Chai W, Liu X, Li J, Sun L J Thorac Dis. 2024; 16(6):3764-3781.
PMID: 38983163 PMC: 11228747. DOI: 10.21037/jtd-24-8.